Recent 13F filings as of December 2025 show that 149 institutional investors hold a position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 31 Dec, 2025 | 8,963,500 | 3,197,410 | 55.45% | $92,772,225.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 7,648,268 | 0 | 0.00% | $79,159,574.00 |
| BVF INC/IL | 31 Dec, 2025 | 5,750,683 | 0 | 0.00% | $59,519,569.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,400,296 | 230,334 | 5.52% | $45,543,064.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,298,504 | 355,179 | 12.07% | $34,139,516.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 3,114,132 | 811,960 | 35.27% | $32,231,266.00 |
| Blue Owl Capital Holdings LP | 31 Dec, 2025 | 2,350,972 | -160,000 | -6.37% | $24,332,560.00 |
| STATE STREET CORP | 31 Dec, 2025 | 2,197,338 | 520,024 | 31.00% | $22,742,448.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 1,932,106 | 1,668,289 | 632.37% | $19,997,297.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 1,705,960 | 0 | 0.00% | $17,656,686.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 1,379,965 | 0 | 0.00% | $14,282,638.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,302,262 | 6,942 | 0.54% | $13,481,334.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 1,237,043 | 1,237,043 | 0.00% | $12,803,395.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 1,193,410 | 0 | 0.00% | $12,351,794.00 |
| Nextech Invest, Ltd. | 31 Dec, 2025 | 1,141,145 | 0 | 0.00% | $11,810,851.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 848,769 | -335,052 | -28.30% | $8,783,184.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 766,934 | 366,780 | 91.66% | $7,937,772.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 721,864 | -262,096 | -26.64% | $7,471,292.00 |
| GREAT POINT PARTNERS LLC | 31 Dec, 2025 | 634,032 | 634,032 | 0.00% | $6,562,231.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 631,706 | 102,298 | 19.32% | $6,538,157.00 |